MedTrace Logo

Africa COVID-19 Vaccine Hesitancy

NCT04912284 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4977

Last updated 2021-06-21

No results posted yet for this study

Summary

Vaccine hesitancy is defined by the WHO's Strategic Advisory Group of Experts on Immunization as a 'delay in acceptance or refusal of vaccination despite availability of vaccination services'. This varies in form and intensity based on when and where it occurs and what vaccine is involved. Several prophylactic vaccines against COVID-19 are currently available. As the world is beginning the roll-out the first approved vaccines, little is known about people's potential acceptance of a COVID-19 vaccine in most of the African countries. ACHES (African COVID -19Vaccine Hesitancy) is an observational study aimed at measuring COVID-19 vaccine hesitancy in five west African countries and exploring causes behind the hesitancy with the main objective of informing guidelines for the proficient roll-out of the vaccines in the region.

Conditions

  • Covid19

Sponsors & Collaborators

  • Institut de Recherche en Sciences de la Sante, Burkina Faso

    collaborator OTHER_GOV

  • University of Bamako

    collaborator OTHER

  • Cheikh Anta Diop University, Senegal

    collaborator OTHER

  • University of Sierra Leone

    collaborator OTHER

  • Gamal Abdel Nasser University of Conakry

    collaborator OTHER

  • Bernhard Nocht Institute for Tropical Medicine

    lead OTHER_GOV

Principal Investigators

  • Daniela Fusco, PhD · Bernhard Nocht Institute for Tropical Medicine

  • Henri Gautier Ouedraogo, Prof · University of Ouagadougu

  • Alpha Mahmoud Barry, Dr · Santé Plus

  • Seydou Doumbia, Prof · University of Bamako

  • Sylvain Faye, Prof · Cheikh Anta Diop University, Senegal

  • Abdullah Mbawah, Dr · University of Freetown

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2021-06-06
Completion
2021-06-06

Countries

  • Burkina Faso
  • Guinea
  • Mali
  • Senegal
  • Sierra Leone

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04912284 on ClinicalTrials.gov